Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695-1705.

Transcatheter aortic-valve replacement (TAVR) has been increasingly used as an alternative to surgery for treating patients with severe, symptomatic aortic stenosis. 1,2 Randomized trials of both ...

November 2, 2011 (Silver Spring, Maryland) — The US Food and Drug Administration has approved the first-ever transcatheter valve for the treatment of inoperable aortic-stenosis disease, the ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV ...

Your doctor can help you weigh your options. A newer approach allows you to get a fresh valve without open-heart surgery. It’s called transcatheter aortic valve replacement, or TAVR.

BETHESDA, MA — The US Food and Drug Administration (FDA) has extended the indication for the Sapien XT and Sapien 3 (Edwards Lifesciences) transcatheter aortic valves to include patients at ...